Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Risankizumab's trials
FORTIFY
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Risankizumab IV
Ongoing
Active not recruiting
Phase 3
Open NCT03105102 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
FORTIFY · Trial Tracker · ComplyRx
